To evaluate the site(s) and mechanism(s) of glucocorticoidinhibition of transforming growth factor (TGF) ␤ receptor (T␤R) mRNA expression in ovarian cells, steady-state levels of T␤R mRNA in hamster preantral follicles exposed to FSH or estradiol with or without dexamethasone were determined by reverse transcription polymerase chain reaction and Southern hybridization. The effect of dexamethasone on follicular DNA and steroid synthesis and the expression of NF-Y and Sp3 were also investigated. Dexamethasone differentially inhibited FSH-or estradiol-induced expression of T␤R mRNA in preantral follicles at all stages. Dexamethasone also strongly inhibited FSH-induced but not TGF␤2-induced follicular DNA synthesis, and the inhibition was completely reversed by TGF␤2. However, TGF␤2 markedly attenuated FSH ؉ dexamethasone-stimulated progesterone and FSH-induced follicular estradiol synthesis. Both FSH and estradiol upregulated NF-YA expression, but the effect was significantly attenuated by dexamethasone. Our results suggest that suppression of NF-YA levels is one of the mechanisms whereby dexamethasone reduces hormone-induced T␤RI and T␤RII mRNA levels in hamster preantral follicles. Dexamethasone potentiates the effect of FSH on granulosa cell steroidogenesis, whereas TGF␤ counteracts the effect. These data indicate that glucocorticoid and TGF␤ may form an important regulatory loop to modulate FSH regulation of preantral follicular growth and differentiation. estradiol, follicle, follicular development, growth factors, ovary
INTRODUCTION
Intraovarian growth modulators, such as epidermal growth factor (EGF)/transforming growth factor (TGF) ␣, insulin-like growth factor (IGF) I, TGF␤, and growth differentiation factor 9 [1] [2] [3] [4] [5] may influence FSH action on granulosa cells. Cell type-specific expression of TGF␤1 and TGF␤2, two important members of the TGF␤ superfamily of ligands [6] , occurs in hamster ovarian cells [7] . Ovarian expression of TGF␤ has also been reported for other species [2, [8] [9] [10] . Whereas TGF␤2 is predominantly expressed in hamster granulosa cells and is upregulated by FSH [11] , TGF␤ receptor type I (T␤RI) and type II (T␤RII) are ex- pressed in granulosa cells, and the expression of both types is induced by FSH [7] . FSH increases T␤RI and T␤RII mRNA levels in hamster ovarian cells, and the effect is markedly attenuated by dexamethasone [12] . Granulosa cell functions may be influenced by juxtacrine and paracrine effects of other ovarian cell types, but whether glucocorticoid directly affects granulosa cell T␤R mRNA levels and the possible mechanism(s) involved remain unknown.
Transcriptional regulation of T␤R gene expression may be a major regulatory mechanism modulating TGF␤ action on follicular cells. Both T␤RI and T␤RII genes have an inverted CCAAT box motif at the 5Ј flanking region [13, 14] that binds nuclear factor (NF) Y [15, 16] , which is an evolutionarily conserved ubiquitous factor consisting of NF-YA, NF-YB, and NF-YC subunits [17] [18] [19] . Whereas dimerization of NF-YB and NF-YC is essential for NF-YA interaction, NF-YA influences transcriptional activity at multiple levels, such as increasing the DNA affinity of other transcription factors that bind to the neighboring enhancer elements, participating in the correct positioning of other transcription factors, and interacting with the TATA binding protein (TBP) complex and proteins that have intrinsic histone acetyltransferase activity [20] [21] [22] [23] . Chang et al. [15] reported that binding of transcription factor CBFa1 (also NF-YA) to the inverted CCAAT box motif induces T␤RI promoter activity in osteoblast cells, and glucocorticoid interferes with the process by suppressing NF-YA expression. Similarly, Park et al. [24] demonstrated that inhibition of histone deacetylase activity in MCF-7 or ZR-25 human breast cancer cells results in the induction of T␤RII promoter activity by the recruitment of the PCAF protein, which is a transcriptional coactivator with intrinsic histone acetyltransferase activity, to the NF-YA complex that binds to the inverted CCAAT box in the T␤RII promoter. However, Kelly et al. [16] documented that NF-YA binding to the consensus DNA binding site in mouse embryonal carcinoma cells reduces T␤RII reporter gene expression, but binding of activating transcription factor 1 (ATF-1) to the positive cis-regulatory element of T␤RII promoter results in strong expression of the reporter gene construct. Similarly, the binding of Sp3 transcription factor to T␤RI or T␤RII promoter in MCF-7E cells leads to significant reduction in promoter-reporter activity [25] . Collectively, transcription of the T␤R gene appears to be regulated by a concerted action of positive and negative transcriptional regulators. Therefore, hormones that influence the levels of these transcription factors in granulosa cells probably will affect T␤R mRNA levels and consequently TGF␤ action on cells. It is not clear, however, whether the levels of any of these transcription factors in preantral follicular cells are influenced by FSH, estrogen, or glucocorticoid. We investigated whether FSH or estradiol would affect follicular T␤RI and T␤RII mRNA levels by upregulating NF-YA or downregulating Sp3 transcriptional coactivators in preantral follicles at different stages of development, and whether dexamethasone would inhibit the effect.
MATERIALS AND METHODS
Golden hamsters (90-100 g) were purchased from SASCO (Madison, WI) and maintained in a 14L:10D cycle in a climate-controlled facility according to Institutional Animal Care and Use Committee (IACUC) and USDA guidelines. The use of hamsters for this study was approved by the IACUC. Ovine FSH-19 was purchased from the National Pituitary Program, (Harbor-UCLA, Los Angeles, CA), estradiol cipionate (5 mg/ml) for human injection was from Pharmacia-Upjohn (Kalamazoo, MI), polyclonal antibodies to NF-YA and NF-YB were from Rockland Scientific (Gilbertsville, PA), polyclonal antibody to Sp3 was from Santa Cruz Biotechnology (Santa Cruz, CA), [ Ovaries were removed on the morning of proestrus (Day 4) when serum FSH levels were the lowest [26] . Preantral follicles at stages 2-4 (stages 2-4 ϭ two to four layers of granulosa cells [GCs], respectively; stage 5 ϭ five or six layers of GC without theca [27] ) were isolated by enzymatic dissociation [27] , and follicles at stage 6 (seven or eight layers of GC and theca [27] ) and stage 7 (follicles with incipient antrum [27] ) were microdissected. Follicles at different stages were cultured (50 at stages 2-4, 20 at stage 5, and 10 each at stage 6 and stage 7) separately in 1 ml Dulbecco modified Eagle medium supplemented with ITS ϩ (final concentration: 6.25 g insulin, 6.25 g transferrin, and 6.25 ng selenium with 5.35 g/ml linoleic acid), 10 units of penicillin G, 10 g streptomycin sulfate, 0.25 g amphotericin B solution (Invitrogen, Carlsbad, CA), and 50 mg BSA at 37ЊC in a Haereus incubator under 5% CO 2 in air for 24 h. Experiment 1 was conducted to determine whether dexamethasone influenced FSH-or E 2 -induced increase in T␤RI and T␤RII receptor mRNA levels. Follicles were incubated without or with 0.235 IU/ml of FSH or 36 nM/ml E 2 . The effect of FSH or E 2 was challenged with a simultaneous administration of 100 nM dexamethasone. Follicles were retrieved, rinsed in ice-cold PBS (pH 7.4), and stored at Ϫ80ЊC until used in RT-PCR analysis.
Experiment 2 was conducted to determine whether dexamethasone, in addition to affecting T␤R transcript levels, interferes with the function of the receptor in granulosa cells. Follicles were incubated with 10 ng/ml TGF␤2 in the absence or presence of 100 nM dexamethasone and 1 Ci/ ml [ 3 H]-thymidine (TdR). Following culture, follicles were used for the quantification of TdR incorporation as an index of follicular DNA synthesis.
FSH stimulates follicular DNA synthesis and T␤R induction. Therefore, experiment 3 was conducted to determine whether dexamethasone influences other key functions of FSH in preantral follicles. Follicles were incubated with 0.235 IU/ml FSH, 10 ng/ml TGF␤2, or 100 nM dexamethasone, either alone or combined, and 1 Ci/ml TdR. Following culture, follicles were used for the quantification of TdR incorporation in the DNA as an index of follicular DNA synthesis. Medium was saved for determination of the levels of progesterone (P) and E 2 produced by follicles in response to test factors.
Because Sp3 and NF-YA/NF-YB regulate T␤R gene expression in various cell lines [17] , experiment 4 was conducted to evaluate whether FSH or E 2 influence the levels of any of these transcriptional modulators as a potential mechanism for upregulating T␤R mRNA levels and whether dexamethasone interferes with the process. For this experiment, we used both in vivo and in vitro approaches.
For the in vitro approach, follicles at stages 6 and 7 were incubated with 0.235 IU/ml FSH with or without 100 nM dexamethasone for 24 h and were then used for immunoblotting detection and quantification of Sp3 and NF-YA. For the in vivo approach, adult hamsters were hypophysectomized on Day 1 (estrus) and injected s.c. on the 10th day with twice daily doses of 5 g FSH or 0.1 ml of 0.5% BSA/saline as a vehicle control for 2 days before ovary retrieval. Some of the FSH-treated hamsters also received a single s.c. dose of 0.5 mg dexamethasone 24 h before ovary retrieval. Another group of hypophysectomized hamsters were injected s.c. with a single dose of 0.5 mg estradiol-cipionate without or with a simultaneous s.c. injection of 0.5 mg dexamethasone at a different location or were given a single s.c. injection of 0.5 mg dexamethasone. Ovaries were collected 48 h after the first FSH injection and 24 h after the steroid injection and then snap frozen on dry ice for immunofluorescence detection of NF-YA expression in follicular and ovarian cells.
Semiquantitative RT-PCR Analysis of Follicular T␤ RI, T␤ RII, and S4 Ribosomal Protein mRNA Levels
Total follicular RNA was extracted using Tri-Reagent according to the procedure described by Roy [12] and Yang and Roy [28] , and 0.3 g RNA was used for semiquantitative RT-PCR analysis of receptor and S4 mRNA as described previously [12] . S4 mRNA was selected because no change in the expression patterns was noted between stages of follicles or following any treatment. Southern hybridization was performed according to the method of Schatz et al. [29] and as described previously [12] . The signal was quantified using a Packard cyclone PhosphorImager and Optiquant software (Perkin-Elmer, Norwalk, CT). After background subtraction, total digital light units (DLU) for the receptor and S4 mRNA was reduced to DLU/min, and the results were expressed as the DLU ratio of the receptor mRNA relative to S4 mRNA.
Measurement of TdR Incorporation into Follicular DNA and Follicular Production of P and E 2
TdR incorporation was performed essentially as described by Roy and Greenwald [30] . The results were expressed as counts per minute of TdR per nanogram of DNA. Levels of P and E 2 accumulated in the medium during in vitro culture were measured using steroid-specific RIAs as described previously [11, 31] . The intra-and interassay coefficient of variations were 5% and 10%, respectively. Steroid levels were expressed as picograms of steroid per milliliter.
Immunoblotting of Follicular Sp3 and NF-YA Protein
The general protocol of immunoblotting was essentially similar to that described previously [7, 28] . Follicles were sonicated in ice-cold 1ϫ RIPA buffer (PBS, pH 7.4, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) containing 0.1 ml protease inhibitor cocktail (Sigma) and centrifuged at 26 000 ϫ g for 15 min at 4ЊC to prepare the lysate. Because of the small amount of follicular material, no attempt was made to separate the nuclear fraction. Equal amounts of protein from each stage and treatment group were fractionated in 10% polyacrylamide gels [32] , electrotransferred to nitrocellulose, and probed overnight with rabbit polyclonal Sp3 or NF-YA antibody in blocking buffer. Jurkat cell lysate was used as a positive control for Sp3 and NF-YA. Following chemiluminescence substrate (WestFemto; Pierce Chemical) reaction, the signal was quantified in a UVP gel documentation system and analyzed with Labworks 4.0 software (Perkin-Elmer). The membrane was then stripped of the antibody using an antibody stripping solution (Pierce), blocked overnight at 4ЊC, and reprobed with a monoclonal ␤-tubulin antibody (Sigma). The quantitative data were normalized against ␤-tubulin signal to correct for any variation in gel loading and to determine the specificity of dexamethasone effect and were expressed as optical density (OD) of respective transcription factor relative to ␤-tubulin. Because NF-YB antibody barely detected NF-YB in a relatively large amount (50 g) of stage 6 follicular protein during antibody optimization and verification, NF-YB was not quantified in experimental samples because only a limited amount of protein for each stage was available.
Immunofluorescence Detection of NF-YA Expression in Follicular Cells
Based on the preliminary results, immunofluorescence detection was performed only for NF-YA. Frozen sections 7 m thick were fixed sequentially for 3 min each in ice-cold methanol and acetone, fixed for 10 min in freshly prepared 4% paraformaldehyde in PBS, pH 7.4, and rinsed three times in PBS at room temperature. Sections were blocked with 10% normal donkey serum (Jackson Immunoresearch, West Grove, PA) in PBS, pH 7.4, containing 0.1% Triton X-100 for 1 h at 4ЊC, followed by a brief rinse in ice-cold PBS and 2-min fixation in freshly made ice-cold 1% paraformaldehyde in PBS. After rinsing three times in PBS at room temperature, sections were incubated overnight with 4 g/ml rabbit anti-NF-YA IgG or nonimmune rabbit IgG (for control) in blocking buffer at 4ЊC. Fluorescence signal was generated by incubating sections with 10 g/ml donkey anti-rabbit IgG (Jackson Immunoresearch) Alexa 488 (Molecular Probes, Eugene, OR) for 1 h at 4ЊC. After thorough rinsing in PBS, nuclei were counterstained with 2 g/ml propidium iodide for 5 min at room temperature, rinsed, mounted with Fluoromount G (Southern Biotechnology Associates, Birmingham, AL), and evaluated under epifluorescence in a DMR research microscope (Leica) equipped with an Optronics Magnafire digital camera (Optronics, Goleta, CA).
For capturing the digital images, the exposure time was adjusted using sections incubated without the primary antibody to subtract any nonspecific or autofluorescence. The signal obtained after background correction was considered the antigen-specific signal. All sections for a specific receptor antigen were evaluated under identical camera settings so that comparison could be made between groups. Immunofluorescence localization studies were repeated at least three times using tissues from different animals to verify the reproducibility of the data. Representative sections were digitally photographed. Photomicrographs were arranged using Adobe Photoshop (San Jose, CA) image editing software without any further adjustment to maintain the true nature of the findings. Fluorescence signal specific for NF-YA was digitized using NIH Image 1.6 software, and the data were expressed as optical density per pixel. Because the intensity of NF-YA immunofluorescence did not vary significantly in granulosa or theca cells across follicles in different stages of development within a group, the data reflect the overall signal intensity in granulosa, theca, or interstitial cells. The mean optical density Ϯ SEM for the interstitial cells was calculated from three different sections representing three different ovaries and for granulosa and theca cells from at least eight follicles in preantral through antral stages present in those same sections.
Statistical Analysis
All experiments were repeated at least three times using follicles from different hamsters to get a sample size of 3 and to ensure reproducibility of the data. Quantitative data were analyzed by one-or two-way ANOVA with Scheffé post hoc test using StatView 4.1 (Abacus Concepts, San Jose, CA). The level of significance was set at 5%.
RESULTS
The steady-state levels of T␤RI and T␤RII mRNA displayed a differential expression pattern in preantral follicles at different stages of development (Figs. 1 and 2) . T␤RII mRNA levels were at least 2.5-fold higher than those of T␤RI (compare the scales for Figs. 1 and 2) . FSH significantly increased both T␤RI and T␤RII levels at all stages; however, dramatic increases were noted for follicles at stages 5-7 ( Figs. 1 and 2) . Although E 2 significantly (P Ͻ 0.05) increased the mRNA levels for both receptor subtypes ( Figs. 1 and 2 ), its effect on T␤RII mRNA levels was quite similar to that of FSH (Fig. 2) . However, E 2 administration caused a 10-fold increase in T␤RI mRNA levels for stage 2 follicles, but its effect on follicles at stages 4-7 was almost identical (ϳ3-to 4-fold; Fig. 1 ). Dexamethasone alone did not display a consistent influence on the basal levels of receptor mRNA, but it significantly attenuated both FSH and E 2 stimulation of increase in receptor mRNA levels, especially levels of T␤RII (Figs. 1 and 2) .
Because dexamethasone displayed such a strong negative influence on T␤R mRNA levels, we investigated whether dexamethasone interferes with effect of TGF␤ on preantral follicular cells. TGF␤2 significantly (P Ͻ 0.05) stimulated DNA synthesis regardless of the stage of follicular development (Fig. 3) ; however, dexamethasone failed to attenuate TGF␤2-induced DNA synthesis. FSH significantly (P Ͻ 0.05) stimulated DNA synthesis in follicles at all stages (Fig. 4) , and its effect on follicles at stages 2-4 was increased further by TGF␤2 (Fig. 3) . Whereas dexamethasone alone had no effect on basal DNA synthesis (same as control), it significantly attenuated FSH-stimulated increase in DNA synthesis in follicles at all stages (Fig. 4) ; however, the effect was blocked by coadministration of TGF␤2 (Fig. 3) . Because FSH also controls steroidogenic functions of preantral follicles [33] , we investigated whether dexamethasone interferes with FSH-induced follicular P and estrogen synthesis in vitro. In contrast to its effect on FSH-induced DNA synthesis, dexamethasone significantly (P Ͻ 0.05) stimulated FSH-induced P synthesis at all stages (Fig. 4) and estrogen synthesis at stage 7 (Fig. 5) . Although TGF␤2 did not affect FSH-induced P production, it completely blocked dexamethasone stimulation of FSH action (Fig. 4 ) and significantly (P Ͻ 0.05) attenuated FSH-in- duced, FSH ϩ dexamethasone-induced, and basal follicular E 2 production (Fig. 5) .
Because dexamethasone inhibited T␤R mRNA levels in preantral follicles at all stages, the levels of transcription factors that might be influenced by dexamethasone were assessed in follicles at later stages, i.e., stages 6 and 7 together. This approach was necessary to obtain an adequate amount of protein for immunoblot detection of transcription factors. Because of the small number of GCs in preantral follicles, it was not feasible to prepare nuclear extract. The Sp3 antibody detected a 100-kDa and a 60-kDa band in all samples (Fig. 6) . However, no change in Sp3 expression was noted following FSH exposure with or without dexamethasone (Fig. 6) . According to the manufacturer, the antibody to NF-YA should detect 35-and 40-kDa bands in positive controls. In our study, the NF-YA antibody detected a 40-kDa protein in Jurkat cell lysate and a 35-kDa protein in NRK cell lysate (Fig. 7A) . The NF-YA antibody detected both protein bands in hamster preantral follicular lysate, confirming the specificity of the antibody. The basal expression of 40-kDa NF-YA was low and was not influenced by dexamethasone treatment (Fig. 7, A and B) . FSH significantly (P Ͻ 0.05) increased the levels of 40-kDa NF-YA protein, but the effect was suppressed by dexamethasone (Fig. 8, A and B) . Similarly, the expression of the 35-kDa NF-YA protein increased significantly (P Ͻ 0.05) following FSH exposure, but it was markedly attenuated by dexamethasone (Fig. 7, A and B) .
For immunofluorescence photomicrography, antigenspecific signal was overlaid on nucleus-specific signal to identify nuclear or nonnuclear localization of the NF-YA. Because NF-YA-specific fluorescence was green and the FIG. 4 . Potentiation of FSH-induced follicular P production by dexamethasone and its inhibition by TGF␤2. Stages 2-4 ϭ preantral follicles with two to four layers of GCs; stages 5 and 6 ϭ preantral follicles with five or six and seven or eight layers of GCs, respectively; stage 7 ϭ follicles with an incipient antrum. Values with same letter are not significantly different from each other (P Ͻ 0.05).
FIG. 5. TGF␤2 inhibition of FSH-induced
follicular E 2 synthesis in vitro. Stages 6 ϭ preantral follicles with seven or eight layers of GCs, respectively; stage 7 ϭ follicles with an incipient antrum. Values with same letter are not significantly different from each other (P Ͻ 0.05).
corresponding nuclear signal was red, overlays were yellow. The shade of the yellow became more greenish with increasing expression of NF-YA protein and finally became green when very high levels of transcription factor were present.
Immunofluorescence studies revealed that NF-YA is expressed exclusively in the nuclei of granulosa and interstitial cells and in oocytes of primordial (S0) and primary (S1) follicles (Fig. 8, A-H) . NF-YA immunoreactivity decreased noticeably in the oocyte when follicles reached the secondary stages (i.e., S2-S6; Figs. 8B and 9A). Distinct NF-YA signal was present in GCs of primordial follicles (arrowheads, Fig. 8A ). Basal levels of NF-YA remained in GCs following hypophysectomy, but only a few interstitial cells displayed NF-YA signal and the intensity was modest (Figs. 8A and 9B) . FSH administration for 48 h resulted in a marked increase in NF-YA immunoreactivity in GCs; however, theca cells wherever present and interstitial cells adjacent to follicles also displayed intense immunofluorescence signal (Figs. 8B and 9B ). Marked increase in NF-YA signal was also noted in mural and antral GCs and in cumulus cells of large antral follicles (S10); however, NF-YA signal in the oocyte was modest (Fig. 8C) . Most notably, E 2 stimulated NF-YA expression in granulosa as well as in interstitial cells beyond that observed in FSH-treated ovaries (Figs. 8D and 9B) . No NF-YA-specific immunofluorescence was detected when E 2 -treated ovary sections were incubated without the antibody, indicating the specificity of the antibody and immunofluorescence signal (Fig. 8E) . Differential staining of granulosa versus interstitial cells in hypophysectomized hamster ovaries also confirmed the immunolocalization data.
Dexamethasone alone did not significantly affect basal NF-YA expression (Figs. 8F and 9B) ; however, it markedly reduced both FSH-and E 2 -induced increase in NF-YA immunosignal in granulosa, theca, and interstitial cells (Figs. 8, G and H, and 9B). The decline was more pronounced in the interstitial cells of E 2 -treated ovaries (Fig. 8H) .
DISCUSSION
The results of the present study suggest that glucocorticoids play a major role in regulating TGF␤ action on GCs by modulating the levels of T␤R mRNA, and the mechanism(s) may involve the reduction in the level of cellular NF-YA, a transcription factor that upregulates T␤R promoter activity in many cell types [24] . FSH and estrogen can initiate a network of signaling pathways to regulate the physiology of GCs [34, 35] . The results of our study also indicate that hormone action on GCs may involve different signaling intermediates for different stages of follicles depending on the magnitude of cellular differentiation and hormone responsiveness. Although it has been suggested that serum-and glucocorticoid-induced kinase (sgk) may participate in FSH-mediated GC activities [35] , whether glucocrticoids induce sgk in GCs with consequent alteration in FSH-induced ovarian gene expression remains to be determined. However, increased sgk activity during FSH-induced rat GC differentiation has been reported [34] . The signaling intermediates, whose expression or functions in GCs are modulated by glucocorticoids, are virtually unknown. Nevertheless, based on the current understanding of the mechanisms of glucorticoid modulation of cell functions, primarily in the context of cells involved in the immune response [36] , we speculate that modulation of signal transduction and transcriptional repression by protein-protein interaction can both be involved in the effect of dexamethasone on preantral follicular cells.
Although the results of this study cannot definitively determine whether NF-YA actually stimulates T␤R promoter activity in GCs, based on the evidence obtained in other cell types this action is highly likely. Nevertheless, our data do not support the hypothesis that Sp3 is a transcriptional repressor of T␤R in GCs. Because analysis of promoter activity requires cell culture, the present model of intact preantral follicles is not compatible with that approach. Results of the present study provide strong evidence that the effect of glucocorticoid on T␤R mRNA levels in preantral granulosa cells is not mediated by other nonfollicular cells in the ovary. The basal steady-state levels of receptor mRNA, even after 24 h of culture without any hormonal supplements, indicate that T␤R mRNA is stable and any increase following FSH or E 2 administration reflects the transcription of the receptor gene. The different basal levels of T␤RI and T␤RII mRNA in preantral follicles across stages indicate that receptor subtype expression varies as preantral follicles grow under endogenous hormonal conditions. The different expression patterns of T␤R mRNA following FSH or E 2 administration clearly demonstrate that preantral follicles at all stages are not identical in functions and regulation. The stronger negative impact of dexamethasone on T␤RII mRNA levels suggests that FSH (at least partly via E 2 ) or E 2 regulation of T␤RII gene expression may be more critically controlled by glucocorticoid. This contention stems from the fact that T␤RII binds to TGF␤ ligands [37] ; hence, regulation of the levels of this subtype may form the first step for precise control of TGF␤ action on follicular cells, particularly as preantral follicles develop. The presence of intense NF-YA-specific signal in primordial and primary oocytes despite the absence of T␤R mRNA or protein [7] (unpublished results) suggests that NF-YA may be involved in the expression of genes important for early oocyte development. Conversely, NF-YA may act as a repressor for certain genes whose expression is vital for oocyte development and maturation in later stages of follicle development. Specific studies are needed to address this issue.
FSH-mediated GC proliferation involves EGF and TGF␤ in the hamster [4, 38, 39] , rat [40, 41] , and pig [42, 43] and IGF-I in the pig [44] ; therefore, glucocorticoid regulation may reflect an important mechanism that governs this intricate process. Whereas T␤R mRNA levels decrease fol- lowing the gonadotropin surge [12] , TGF␤2 protein expression in preantral GCs increases [11] , coinciding with increased DNA synthesis [45] . These lines of evidence and the results of the present study suggest that although dexamethasone reduces T␤R mRNA levels, it does not alter existing T␤R protein in GCs, at least during the initial phase of the culture, thus allowing TGF␤ to bind its receptor and counteract the effects of dexamethasone on FSHstimulated DNA and steroid hormone synthesis. This lack of effect is further evident from the inability of dexamethasone to influence the FSH effect in the presence of TGF␤2. Therefore, glucocorticoids probably affect TGF␤ action on preantral follicles by modulating TGF␤ receptor gene expression rather than postreceptor signaling mechanisms of TGF␤. However, dexamethasone enhancement of FSH-stimulated follicular steroid production and attenuation of FSH-and estrogen-mediated NF-YA synthesis indicate that glucocorticoids modulate FSH and estrogen receptor activation and/or downstream signaling necessary for these biological responses. Recently, Imasato et al. [46] and Shuto et al. [47] demonstrated that dexamethasone upregulates Toll-like receptor 2 expression in HeLa cells by suppressing p38-mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1 upregulation. Although our data document a dexamethasone-induced suppression of FSH/ estrogen-stimulated T␤R gene expression in GCs, the involvement of one or more glucocorticoid-modulated intermediary factors cannot be ruled out. The expression pattern of NF-YA appears to be one such factor; however, additional studies are needed to address this issue and the mechanism thereof in detail.
The lack of TGF␤2 effect on FSH-induced follicular P production but its attenuation of FSH-induced E 2 production suggests that TGF␤ differentially influences FSH-regulated follicular steroidogenesis. TGF␤ augments FSHstimulated P production by rat GCs in vitro [48] , but it inhibits FSH-stimulated P production by porcine GCs [42] . Such discrepancy in TGF␤ action may be due to species FIG. 10. FSH alone or via estrogen stimulates the synthesis of NF-YA, which participates in the activation of T␤R promoters, resulting in T␤R synthesis. Consequently, enhanced TGF␤ action leads to DNA synthesis and cell cycle progression and follicle growth. Glucocorticoids suppress TGF␤ action by blocking T␤R transcription via reduced NF-YA synthesis but potentiate FSH-induced GC steroidogenesis and functional differentiation. TGF␤, in turn, controls GC differentiation by counteracting the glucocorticoid effect. Therefore, FSH, E 2 , glucocorticoids, and TGF␤ form a unique regulatory loop for the orderly progression of GC proliferation and differentiation during preantral folliculogenesis.
variation. The synergism of dexamethasone and FSH in follicular P production and its inhibition by TGF␤2 indicates that glucocorticoid and TGF␤ interaction may be necessary for GC differentiation as the follicle matures through the preantral stages. Hsueh and Erickson [49] demonstrated that either cortisol or dexamethasone significantly stimulates P production by rat GCs in culture, thus corroborating our findings. Although glucocorticoid inhibits FSH-induced increase in aromatase activity, it does not affect the activity of preexisting aromatase activity in rat GCs [49] . A similar situation may explain the lack of dexamethasone effect on follicular E 2 synthesis in the hamster.
These results provide strong evidence to suggest that inhibition of NF-YA expression is one of the mechanisms whereby glucocorticoids suppress T␤RI and T␤RII mRNA levels in hamster preantral follicles. A model explaining the effect of FSH, estrogen, TGF␤, and dexamethasone interaction with reference to T␤R and NF-YA expression during follicular development has been proposed (Fig. 10) . Future studies will focus on the intracellular signaling pathway that is interrupted by dexamethasone to bring about reduced NF-YA expression.
